Pharmacoeconomic analysis of using drugs containing mycophenolic acid in kidney transplant recipients in the context of domestic pharmaceutical market
DOI:
https://doi.org/10.14739/2409-2932.2015.2.45152Keywords:
Mycophenolic Acid, Kidney Transplantation, Pharmaceutical EconomicsAbstract
Aim. The use of mycophenolic acid (MPA) in patients after kidney transplantation made it possible to achieve significant results in reducing the number of acute rejection of kidney in recipients, and increasing the long-term survival of transplant.
Methods and results. With the aim of evaluation of the clinical and economic feasibility of conversion kidney transplant recipients from EC-MPS to MMF in the setting of Ukrainian pharmaceutical market, pharmacoeconomic cost minimization method has been investigated a coefficient of «missed opportunities» in the conversion to a less expensive therapy has been calculated, and the analysis of the impact on the budget has been performed.
Conclusion. It has been determined, that the results of pharmacoeconomic calculations present the strong evidence of the economic advantage of MMF over EC-MPS and the feasibility of MMF in patients receiving immunosuppressive therapy with MPA.
References
Domhan S., Muschal S., Schwager C. et al. (2008) Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol. Cancer Ther, 7, 1656-1668
Chen H, Chen B. (2014) Clinical mycophenolic acid monitoring in liver transplant recipients. World J Gastroenterol, 20(31), 10715-10728.
Sollinger H.W., Sundberg A.K., Leverson G. et al. (2010) Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients. Transplantation, 89 (4), 446-451.
Sollinger H. (2004) Enteric-coated mycophenolate sodium: therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients. Transplant Proc., 36, 517S-520S.
Ciancio G., Burke G.W., Gaynor J.J. [et al. (2011) Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplantation With Tacrolimus and Steroid Avoidance: Four-Year Analysis. Transplantation, 91 (11), 214-218
Langone J., Chan L., Bolin P. et al. (2011) Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance: a multicenter, doubleblind, randomized study. Transplantation, 91, 470-478.
Ciancio G., Burke G.W., Gaynor J.J. et al. (2008) Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplant Recipients Given Tacrolimus and Daclizumab/Thymoglobulin: One Year Follow-Up. Transplantation, 86, 67–74.
Rascati K.L. (2008) Essentials of pharmacoeconomics – Lippincott Williams & Wilkins, 20. – 310 р.
Heemann U. et all. (2011) Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant., 26, 2099–2106.
Morris P., Knechtle S.J. (2014) Kidney Transplantation - Principles and Practice. Elsevier Health Sciences 880 p.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
